Understanding how fetal DNA travels in a pregnant woman’s blood could unlock the next generation of prenatal screening, according to a new paper published in Science Advances today. An international ...

A ten-year study of 849 pregnancy loss samples demonstrates that chromosomal microarray testing detects genetic abnormalities in over sixty-two percent of cases, with risk rising steeply alongside ...

Understanding how fetal DNA travels in a pregnant woman's blood could unlock the next generation of prenatal screening, according to a new paper published in Science Advances. An international team of ...

SneakPeek®, the first at-home early fetal sex test for use at six weeks, is now available at over 8,800 retail locations nationwide SALT LAKE CITY, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, ...

JA Rosenfeld is an employee of Signature Genomic Laboratories, a subsidiary of PerkinElmer, Inc. The authors have no other relevant affiliations or financial involvement with any organization or ...

The global cell-free fetal DNA testing market size was valued at USD 1.62 billion in 2025 and is projected to grow from USD 1.71 billion in 2026 to USD 2.64 billion by 2034, registering a CAGR of 5.56 ...

Understanding how fetal DNA travels in a pregnant woman's blood could unlock the next generation of prenatal screening, according to a new paper published in Science Advances. Subscribe to our ...

Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...

Definition: A microarray is a small, flat substrate carrying an ordered grid of microscopic probe features, each containing a known biological molecule, that is used to measure many molecular targets ...